Ovid Therapeutics Inc

NASDAQ:OVID   3:59:52 PM EDT
3.39
-0.06 (-1.74%)
Earnings Announcements

Ovid Therapeutics Reports Second Quarter 2021 Financial Results

Published: 08/16/2021 12:22 GMT
Ovid Therapeutics Inc (OVID) - Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights.
Ovid Therapeutics Inc Quarterly Loss per Share $0.23.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.